Term ends Nov 15, 2033 · Medium confidence
20-year base term ends Nov 15, 2033
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,875,893), so the cap could be lower.
Nov 15, 2013
Nov 15, 2033
Apr 5, 2022
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 15, 2013, when application PCT/US2013/070417, the earliest non-provisional in its chain, was filed (this one was filed Jun 25, 2020) | Nov 15, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,035,822, US 10,875,893, US 11,040,107) | resolves to Nov 15, 2033, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 15, 2033 | Medium confidence |
This family
| Application PCT/US2013/070417 | PCT application no patent term | no patent term |
| US 10,035,822 | In force Nov 2033 | Nov 2033 |
| US 10,875,893 | In force no later than Nov 2033 | no later than Nov 2033 |
| US 11,292,815 | this patent Nov 2033 | Nov 2033 |
| Application 17/673,703 | Abandoned not computed | not computed |
| Application 18/905,256 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 13, 2020 Reel 54043, frame 366 | Francois, Cedric; Deschatelets, Pascal | Apellis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Nov 18, 2021 Reel 58149, frame 828 | Francois, Cedric; Deschatelets, Pascal | Apellis Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| May 13, 2024 Reel 67398, frame 261 | Apellis Pharmaceuticals, Inc. | Sixth Street Lending Partners | Security Interest |
| May 15, 2026 Reel 75652, frame 212 | Sixth Street Lending Partners, in Its Capacity as Administrative Agent | Apellis Pharmaceuticals, Inc. | Release of Patent Security Agreement Recorded at Reel 067398 and Frame 0261 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,035,822, US 10,875,893, US 11,040,107, ends no earlier than this term, so it caps nothing.